The Merck Druggernaut: The Inside Story of a Pharmaceutical Giant

The Merck Druggernaut: The Inside Story of a Pharmaceutical Giant - Paperback

$20.95
Sale price  $20.95 Regular price 
Skip to product information
The Merck Druggernaut: The Inside Story of a Pharmaceutical Giant

The Merck Druggernaut: The Inside Story of a Pharmaceutical Giant - Paperback

$20.95
Sale price  $20.95 Regular price 

Reliable shipping

Flexible returns

by Fran Hawthorne (Author)

"The Merck Druggernaut" blickt hinter die Kulissen eines der weltgrö ten Pharmaunternehmen und beschreibt die Persönlichkeiten, die internen Kämpfe und die geschickten strategischen Manöver, mit denen Merck Marktführer geblieben ist.
"The Merck Druggernaut" - Hier erfahren Sie in allen Einzelheiten, worum es in der Pharmaindustrie wirklich geht.

Front Jacket

PRAISE FOR The Merck Druggernaut

Few business stories involve life and death. This one does, and Fran Hawthorne tells it with insight and verve. This is an important book for anyone who has ever taken a pill or prescribed one (or bought a pharmaceutical share). It ought to be read as carefully as the directions on a prescription bottle.
--Firth Calhoun, Editor at Large, Institutional Investor

Fran Hawthorne has produced a compelling, detail-rich account of how the once-mighty Merck has fallen from its perch atop the drug industry amid the turmoil that has shaken all the players in the business. Anyone seeking to understand the vast changes this critical industry has undergone in recent years should read The Merck Druggernaut.
--Hilary Rosenberg, author of The Vulture Investors and A Traitor to His Class

Back Jacket

PRAISE FOR The Merck Druggernaut

"Few business stories involve life and death. This one does, and Fran Hawthorne tells it with insight and verve. This is an important book for anyone who has ever taken a pill or prescribed one (or bought a pharmaceutical share). It ought to be read as carefully as the directions on a prescription bottle."
--Firth Calhoun, Editor at Large, Institutional Investor

"Fran Hawthorne has produced a compelling, detail-rich account of how the once-mighty Merck has fallen from its perch atop the drug industry amid the turmoil that has shaken all the players in the business. Anyone seeking to understand the vast changes this critical industry has undergone in recent years should read The Merck Druggernaut."
--Hilary Rosenberg, author of The Vulture Investors and A Traitor to His Class

Author Biography

FRAN HAWTHORNE, a senior contributing editor of Institutional Investor, has connections deep within the business and finance communities. Hawthorne has been covering business and healthcare for more than twenty years for such publications as Fortune, BusinessWeek, and Crain's New York Business. She is the author of Inside the FDA, which is also published by Wiley.

Number of Pages: 290
Dimensions: 0.85 x 8.76 x 5.72 IN
Publication Date: February 01, 2005

You may also like